JP2001524938A5 - - Google Patents

Download PDF

Info

Publication number
JP2001524938A5
JP2001524938A5 JP1998518632A JP51863298A JP2001524938A5 JP 2001524938 A5 JP2001524938 A5 JP 2001524938A5 JP 1998518632 A JP1998518632 A JP 1998518632A JP 51863298 A JP51863298 A JP 51863298A JP 2001524938 A5 JP2001524938 A5 JP 2001524938A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998518632A
Other languages
English (en)
Japanese (ja)
Other versions
JP4195728B2 (ja
JP2001524938A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/018845 external-priority patent/WO1998016111A1/en
Publication of JP2001524938A publication Critical patent/JP2001524938A/ja
Publication of JP2001524938A5 publication Critical patent/JP2001524938A5/ja
Application granted granted Critical
Publication of JP4195728B2 publication Critical patent/JP4195728B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP51863298A 1996-10-16 1997-10-14 プロアントシアニジンポリマー止瀉組成物の腸溶製剤 Expired - Fee Related JP4195728B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73077296A 1996-10-16 1996-10-16
US08/730,772 1996-10-16
PCT/US1997/018845 WO1998016111A1 (en) 1996-10-16 1997-10-14 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions

Publications (3)

Publication Number Publication Date
JP2001524938A JP2001524938A (ja) 2001-12-04
JP2001524938A5 true JP2001524938A5 (enExample) 2005-02-10
JP4195728B2 JP4195728B2 (ja) 2008-12-10

Family

ID=24936755

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51863298A Expired - Fee Related JP4195728B2 (ja) 1996-10-16 1997-10-14 プロアントシアニジンポリマー止瀉組成物の腸溶製剤

Country Status (14)

Country Link
US (5) US7341744B1 (enExample)
EP (3) EP0935417B1 (enExample)
JP (1) JP4195728B2 (enExample)
KR (1) KR100467532B1 (enExample)
AT (1) ATE430477T1 (enExample)
AU (1) AU4988197A (enExample)
CA (1) CA2269078C (enExample)
DE (1) DE69739394D1 (enExample)
DK (1) DK0935417T3 (enExample)
ES (1) ES2326933T3 (enExample)
NZ (1) NZ335317A (enExample)
PT (1) PT935417E (enExample)
TW (1) TW537898B (enExample)
WO (1) WO1998016111A1 (enExample)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0935417B1 (en) * 1996-10-16 2009-05-06 Napo Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
WO2000047062A2 (en) * 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
CN1348368A (zh) * 1999-02-15 2002-05-08 日加威士己株式会社 含原花色素作为活性成分的adp-核糖基化抑制剂和治疗肠毒素型细菌感染性疾病的组合物
CN1164262C (zh) * 1999-05-17 2004-09-01 D.B.F.公司 含有植物物质的颗粒及其制备方法
AU2002241307B9 (en) * 2001-03-28 2005-08-11 Asahi Group Holdings, Ltd. Proteotoxin neutralizer
CO5400144A1 (es) 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
JP5171038B2 (ja) 2003-10-10 2013-03-27 エティファルム イチョウ・エキスを含む放出持続性の微小顆粒およびそのような顆粒の製造方法
KR100720817B1 (ko) * 2003-12-26 2007-05-21 (주)아모레퍼시픽 식물 추출물을 함유하는 제제 및 그 제조방법
JP2006232752A (ja) * 2005-02-25 2006-09-07 Tokyo Univ Of Marine Science & Technology コレステロール及び中性脂肪吸収抑制剤及びこれを含む食品
SI1698630T1 (sl) 2005-03-03 2015-01-30 Alfa Wassermann S.P.A. Nove polimorfne oblike rifaksimina, postopki za njihovo pripravo in njihova uporaba v medicinskih pripravkih
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
US20090076132A1 (en) * 2005-03-11 2009-03-19 Gary Pekoe Antiviral compositions and methods of treatment
JP5167461B2 (ja) * 2005-09-16 2013-03-21 国立医薬品食品衛生研究所長 炎症性腸疾患予防剤
US7351853B2 (en) * 2006-01-23 2008-04-01 Albion Advanced Nutrition Method of manufacturing a granular mineral composition
EP2529626B1 (en) * 2006-05-01 2017-11-22 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing colon cancer
US20070254050A1 (en) * 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
WO2007130892A2 (en) * 2006-05-01 2007-11-15 Napo Pharmaceuticals, Inc. Method for treatment of constipation-predominant irritable bowel syndrome
US8048413B2 (en) * 2006-05-17 2011-11-01 Helene Huguet Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
WO2008083513A1 (en) * 2006-12-13 2008-07-17 Beijing Gingko-Group Biological Technology Co., Ltd. Black soybean hull extract and process for preparation and use thereof
WO2008115605A1 (en) * 2007-03-22 2008-09-25 Ibix Clear bismuth treatments and methods for making
CN101715349B (zh) * 2007-05-08 2012-07-18 美国Rq生物科技有限公司 治疗革兰氏阴性细菌感染的治疗组合物及方法
US8734867B2 (en) 2007-12-28 2014-05-27 Liveleaf, Inc. Antibacterial having an extract of pomegranate combined with hydrogen peroxide
EP2252601B1 (en) * 2008-01-24 2012-12-19 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2009131957A2 (en) 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising oxadiazole derivatives
WO2009131958A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising triazine derivatives
US20090270398A1 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Pyridazine Derivatives
US8236838B2 (en) * 2008-04-21 2012-08-07 Institute For Oneworld Health Compounds, compositions and methods comprising isoxazole derivatives
WO2010033626A1 (en) * 2008-09-19 2010-03-25 Institute For Oneworld Health Compounds, compositions and methods comprising imidazole and triazole derivatives
US20100034967A1 (en) * 2008-08-07 2010-02-11 Vector Corporation Dry polymer layering using a rotor processor
US8807070B2 (en) * 2008-08-07 2014-08-19 Vector Corporation Rotor processor for dry powders
US20100034968A1 (en) * 2008-08-07 2010-02-11 Vector Corporation Polymer coating process using dry glidant in a rotor processor
FR2938430B1 (fr) * 2008-11-14 2011-05-20 Debregeas Et Associes Pharma Granules a base de plantes
EP2403938B1 (en) * 2009-03-04 2019-12-11 Liveleaf, Inc. Method and material for site activated complexing of biologic molecules
US8511216B2 (en) * 2009-03-30 2013-08-20 Kanzaki Kokyukoki Mfg. Co., Ltd. Hydraulic actuator unit
US8343976B2 (en) * 2009-04-20 2013-01-01 Institute For Oneworld Health Compounds, compositions and methods comprising pyrazole derivatives
WO2011024049A2 (en) * 2009-08-26 2011-03-03 Glenmark Pharmaceuticals Ltd Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations
US8652534B2 (en) 2009-10-14 2014-02-18 Berry Pharmaceuticals, LLC Compositions and methods for treatment of mammalian skin
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
PL2632550T3 (pl) * 2010-10-31 2017-10-31 Napo Pharmaceuticals Inc Sposoby i kompozycja do leczenia biegunki związanej z HIV
BR112013018688B1 (pt) 2011-01-27 2021-08-24 Napo Pharmaceuticals, Inc Método de produção de uma composição polimérica de proantocianidina
CA2832059C (en) 2011-04-01 2020-07-14 Ocean Spray Cranberries, Inc. Inflammation and immunity treatments
US8722040B2 (en) 2011-06-24 2014-05-13 Liveleaf, Inc. Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites
US9192635B2 (en) 2011-06-24 2015-11-24 Liveleaf, Inc. Method of treating damaged mucosal or gastrointestinal tissue by administering a composition comprising a mixture of pomegranate and green tea extracts and releasably bound hydrogen peroxide
ITBO20110461A1 (it) 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
NZ630125A (en) * 2012-03-13 2017-01-27 Piramal Entpr Ltd Herbal composition for the treatment of metabolic disorders
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
US8716351B1 (en) 2012-12-23 2014-05-06 Liveleaf, Inc. Methods of treating gastrointestinal spasms
ITMI20130476A1 (it) 2013-03-28 2014-09-29 Novintethical Pharma Sagl Composizioni per il trattamento di disturbi gastro-intestinali a base di complessi di tannini con proteine
CN103536583B (zh) * 2013-11-01 2015-02-25 潍坊医学院 一种原花青素缓释纳米微球及制备方法和应用
PT3546464T (pt) 2014-05-12 2020-08-05 Alfasigma Spa Preparação e utilização da forma cristalina tau de rifaximina solvatada com degme
US20170100429A1 (en) * 2014-05-29 2017-04-13 Jaguar Animal Health, Inc. Methods of Treating Diarrhea in Neonatal and Young Non-Human Animals
WO2015184111A1 (en) * 2014-05-29 2015-12-03 Jaguar Animal Health, Inc. Methods of treating salmonella-induced diarrhea in non-human animals
WO2015184109A1 (en) * 2014-05-29 2015-12-03 Jaguar Animal Health, Inc. Methods of treating diarrhea in adult non-human animals
WO2016112312A1 (en) * 2015-01-09 2016-07-14 Jaguar Animal Health Methods of treating diarrhea in companion animals
US20180021297A1 (en) * 2015-02-26 2018-01-25 Jaguar Health, Inc. Use Of Croton- Or Calophyllum-Derived Proanthocyanidin Polymers Or Botanical Extracts In Combination With Rifaximin For The Treatment Of Diarrhea In Non-Human Animals
AU2016222791A1 (en) * 2015-02-26 2017-09-07 Jaguar Health, Inc. Methods of treating diarrhea and promoting intestinal health in non-human animals
WO2018022475A1 (en) * 2016-07-25 2018-02-01 Jaguar Health, Inc Methods of treating porcine epidemic diarrheal virus in piglets
IT201600122310A1 (it) * 2016-12-01 2018-06-01 Sofar Spa Composizione per uso nella terapia di alterazioni dell'intestino
ES3027568T3 (en) 2016-12-15 2025-06-16 Nestle Sa Compositions and methods that modulate bacteria in a companion animal
WO2018222921A1 (en) 2017-05-31 2018-12-06 Napo Pharmaceuticals, Inc. Methods and compositions for treating bile acid diarrhea, diarrhea associated with small intestine resection or gallbladder removal, and short bowel syndrome
IL270984B2 (en) 2017-05-31 2026-05-01 Napo Pharmaceuticals Inc Methods and preparations for treating congenital diarrheal disorder
JP7237014B2 (ja) * 2017-12-27 2023-03-10 サントリーホールディングス株式会社 腸管バリア機能改善用組成物
KR20200008826A (ko) 2018-07-17 2020-01-29 성균관대학교산학협력단 대장균을 이용한 단백질가수분해효소 k의 생산 방법
CN109464491B (zh) * 2018-12-03 2022-02-01 四川省畜牧科学研究院 诃子组合物及其在制备预防和/或治疗腹泻和/或乳房炎的产品中的应用
WO2022115481A1 (en) * 2020-11-24 2022-06-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating post-acute infection gastrointestinal disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2377201A1 (fr) * 1977-01-18 1978-08-11 Fabre Sa Pierre Composition pharmaceutique a activite anti-inflammatoire et vasculotrope
SE446940B (sv) * 1983-02-16 1986-10-20 Carl Axel Virdalm Medel for bekempande av sjukdomstillstand i matsmeltningsapparaten innehallande skal eller ytterdelar av ber eller frukter
US4698360B1 (en) * 1985-04-09 1997-11-04 D Investigations Pharmacologiq Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
DE3564370D1 (en) * 1985-08-30 1988-09-22 Nestle Sa Dietetic product with depurating and antidiarrheal activity and process for its preparation
US5141735A (en) * 1990-06-18 1992-08-25 Hoffman-La Roche, Inc. Substituted amino-benzodiazepines having anitviral activity
US5211944A (en) * 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
SI9011933A (sl) 1990-10-15 1998-06-30 TANIN SEVNICA Kemična industrija p.o. Kostanjev taninski ekstrakt, postopek za njegovo pridobivanje in njegova uporaba
US5234922A (en) 1992-09-28 1993-08-10 University Of Iowa Research Foundation Use of sulfonylureas and other potassium channel regulators to treat secretory diarrhea
US5750496A (en) * 1996-08-12 1998-05-12 Utah State University Method of controlling cryptosporidium infectons using protease inhibitors
EP0935417B1 (en) * 1996-10-16 2009-05-06 Napo Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions

Similar Documents

Publication Publication Date Title
JP2000507118A5 (enExample)
JP2001505052A5 (enExample)
JP2000506348A5 (enExample)
JP2000506264A5 (enExample)
JP2000511629A5 (enExample)
JP2000507714A5 (enExample)
JP2001504101A5 (enExample)
JP2000507756A5 (enExample)
JP2000512449A5 (enExample)
JP2001503087A5 (enExample)
JP2000506650A5 (enExample)
JP2000508469A5 (enExample)
JP2000506747A5 (enExample)
JP2000504267A5 (enExample)
JP2000510734A5 (enExample)
JP2000510560A5 (enExample)
JP2000508675A5 (enExample)
JP2000508289A5 (enExample)
JP2000509128A5 (enExample)
JP2000505356A5 (enExample)
JP2000508067A5 (enExample)
JP2001506737A5 (enExample)
JP2000512333A5 (enExample)
JP2000510844A5 (enExample)
JP2000512101A5 (enExample)